{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T05:19:32Z","timestamp":1741411172907,"version":"3.38.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Basque Government \u2013 BIKAINTEK Program","award":["48-AF-W2-2018-00008"],"award-info":[{"award-number":["48-AF-W2-2018-00008"]}]},{"name":"Basque Country Government (Economic Development & Infrastructures Depart.), HAZITEK program","award":["grant No. ZE-2019\/00004"],"award-info":[{"award-number":["grant No. ZE-2019\/00004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91743-0","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:56:26Z","timestamp":1741337786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The new bilastine eye drop formulation protects against conjunctival dehydration and promotes corneal wound healing in a comparative in vitro study"],"prefix":"10.1038","volume":"15","author":[{"given":"Eider","family":"Arana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gonzalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Andollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"P\u00e9rez-Garrastachu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Otero-Espinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"D\u00edaz-Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Go\u00f1i-de-Cerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"G\u00f3mez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Su\u00e1rez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"1","key":"91743_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.55519\/JAMC-01-9432","volume":"34","author":"A Kausar","year":"2022","unstructured":"Kausar, A., Akhtar, N. & Akbar, N. Epidemiological aspects of allergic conjunctivitis. J. Ayub Med. Coll. Abbottabad. 34 (1), 135\u2013140. https:\/\/doi.org\/10.55519\/JAMC-01-9432 (2022).","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"91743_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13223-020-0403-9","volume":"16","author":"P Dupuis","year":"2020","unstructured":"Dupuis, P., Prokopich, C. L., Hynes, A. & Kim, H. A contemporary look at allergic conjunctivitis. Allergy Asthma Clin. Immunol. 16, 5. https:\/\/doi.org\/10.1186\/s13223-020-0403-9 (2020).","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"4","key":"91743_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/ACI.0000000000000669","volume":"20","author":"N Kimchi","year":"2020","unstructured":"Kimchi, N. & Bielory, L. The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents. Curr. Opin. Allergy Clin. Immunol. 20 (4), 414\u2013420. https:\/\/doi.org\/10.1097\/ACI.0000000000000669 (2020).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"91743_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/JAA.S13705","volume":"3","author":"O Kari","year":"2010","unstructured":"Kari, O. & Saari, K. M. Updates in the treatment of ocular allergies. J. Asthma Allergy. 3, 149\u2013158. https:\/\/doi.org\/10.2147\/JAA.S13705 (2010).","journal-title":"J. Asthma Allergy"},{"issue":"9","key":"91743_CR5","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1111\/all.13786","volume":"74","author":"A Leonardi","year":"2019","unstructured":"Leonardi, A. et al. Management of ocular allergy. Allergy 74 (9), 1611\u20131630. https:\/\/doi.org\/10.1111\/all.13786 (2019).","journal-title":"Allergy"},{"issue":"Suppl 1","key":"91743_CR6","first-page":"11","volume":"19","author":"A del Cuvillo","year":"2009","unstructured":"del Cuvillo, A. et al. Allergic conjunctivitis and H1 antihistamines. J. Investig Allergol. Clin. Immunol. 19 (Suppl 1), 11\u201318 (2009).","journal-title":"J. Investig Allergol. Clin. Immunol."},{"issue":"43","key":"91743_CR7","doi-asserted-by":"publisher","first-page":"39603","DOI":"10.1021\/acsami.9b13851","volume":"11","author":"S Lin","year":"2019","unstructured":"Lin, S. et al. Overcoming the anatomical and physiological barriers in topical eye surface medication using a Peptide-Decorated polymeric micelle. ACS Appl. Mater. Interfaces. 11 (43), 39603\u201339612. https:\/\/doi.org\/10.1021\/acsami.9b13851 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"91743_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1124\/jpet.119.256933","volume":"370","author":"V Gote","year":"2019","unstructured":"Gote, V., Sikder, S., Sicotte, J. & Pal, D. O. Drug delivery: present innovations and future challenges. J. Pharmacol. Exp. Ther. 370 (3), 602\u2013624. https:\/\/doi.org\/10.1124\/jpet.119.256933 (2019).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"91743_CR9","doi-asserted-by":"publisher","unstructured":"Yang, Y. & Lockwood, A. Topical ocular drug delivery systems: Innovations for an unmet need. Exp Eye Res. ;218:109006. (2022). https:\/\/doi.org\/10.1016\/j.exer.2022.109006. Epub 2022 Mar 4. PMID: 35248559.","DOI":"10.1016\/j.exer.2022.109006"},{"issue":"6","key":"91743_CR10","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3390\/pharmaceutics14061150","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang, Y. & Wang, C. Novel eye drop delivery systems: advance on formulation design strategies targeting anterior and posterior segments of the eye. Pharmaceutics 14 (6), 1150. https:\/\/doi.org\/10.3390\/pharmaceutics14061150 (2022).","journal-title":"Pharmaceutics"},{"issue":"7","key":"91743_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1046\/j.1440-1681.2000.03288.x","volume":"27","author":"NM Davies","year":"2000","unstructured":"Davies, N. M. Biopharmaceutical considerations in topical ocular drug delivery. Clin. Exp. Pharmacol. Physiol. 27 (7), 558\u2013562. https:\/\/doi.org\/10.1046\/j.1440-1681.2000.03288.x (2000).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"11","key":"91743_CR12","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","volume":"57","author":"A Ludwig","year":"2005","unstructured":"Ludwig, A. The use of mucoadhesive polymers in ocular drug delivery. Adv. Drug Deliv Rev. 57 (11), 1595\u20131639. https:\/\/doi.org\/10.1016\/j.addr.2005.07.005 (2005).","journal-title":"Adv. Drug Deliv Rev."},{"issue":"2","key":"91743_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/pharmaceutics15020470","volume":"15","author":"A Ra\u010di\u0107","year":"2023","unstructured":"Ra\u010di\u0107, A. & Kraji\u0161nik, D. Biopolymers in mucoadhesive eye drops for treatment of dry eye and allergic conditions: application and perspectives. Pharmaceutics 15 (2), 470. https:\/\/doi.org\/10.3390\/pharmaceutics15020470 (2023).","journal-title":"Pharmaceutics"},{"key":"91743_CR14","doi-asserted-by":"publisher","first-page":"120873","DOI":"10.1016\/j.ijpharm.2021.120873","volume":"606","author":"B Silva","year":"2021","unstructured":"Silva, B., S\u00e3o, B. B., Delgado, E. & Gon\u00e7alves, L. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery. Int. J. Pharm. 606, 120873. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120873 (2021).","journal-title":"Int. J. Pharm."},{"key":"91743_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijbiomac.2018.01.120","volume":"110","author":"V Krishnaswami","year":"2018","unstructured":"Krishnaswami, V., Kandasamy, R., Alagarsamy, S., Palanisamy, R. & Natesan, S. Biological macromolecules for ophthalmic drug delivery to treat ocular diseases. Int. J. Biol. Macromol. 110, 7\u201316. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.01.120 (2018).","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"91743_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/polym10030267","volume":"10","author":"M Ways","year":"2018","unstructured":"Ways, M., Lau, T. M. & Khutoryanskiy, W. M. Chitosan and its derivatives for application in mucoadhesive drug delivery systems. Polym. (Basel). 10 (3), 267. https:\/\/doi.org\/10.3390\/polym10030267 (2018).","journal-title":"Polym. (Basel)"},{"issue":"11","key":"91743_CR17","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.addr.2006.07.022","volume":"58","author":"Y Ali","year":"2006","unstructured":"Ali, Y. & Lehmussaari, K. Industrial perspective in ocular drug delivery. Adv. Drug Deliv Rev. 58 (11), 1258\u20131268. https:\/\/doi.org\/10.1016\/j.addr.2006.07.022 (2006).","journal-title":"Adv. Drug Deliv Rev."},{"issue":"7","key":"91743_CR18","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/ijms18071398","volume":"18","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. Dry eye management: targeting the ocular surface microenvironment. Int. J. Mol. Sci. 18 (7), 1398. https:\/\/doi.org\/10.3390\/ijms18071398 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"91743_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.carbpol.2016.07.106","volume":"153","author":"R Salzillo","year":"2016","unstructured":"Salzillo, R. et al. Optimization of hyaluronan-based eye drop formulations [published correction appears in carbohydr polym. 181:1235\u20131236 (2018)]. Carbohydr. Polym. 153, 275\u2013283. https:\/\/doi.org\/10.1016\/j.carbpol.2016.07.106 (2016).","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"91743_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.optm.2010.08.003","volume":"82","author":"MJ Rah","year":"2011","unstructured":"Rah, M. J. A review of hyaluronan and its ophthalmic applications. Optometry 82 (1), 38\u201343. https:\/\/doi.org\/10.1016\/j.optm.2010.08.003 (2011).","journal-title":"Optometry"},{"issue":"5","key":"91743_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00003226-199309000-00010","volume":"12","author":"M Nakamura","year":"1993","unstructured":"Nakamura, M. et al. Characterization of water retentive properties of hyaluronan. Cornea 12 (5), 433\u2013436. https:\/\/doi.org\/10.1097\/00003226-199309000-00010 (1993).","journal-title":"Cornea"},{"issue":"4","key":"91743_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/molecules26040849","volume":"26","author":"S Ali","year":"2021","unstructured":"Ali, S. et al. Crosslinked hyaluronic acid with liposomes and Crocin confers cytoprotection in an experimental model of dry eye. Molecules 26 (4), 849. https:\/\/doi.org\/10.3390\/molecules26040849 (2021).","journal-title":"Molecules"},{"issue":"4","key":"91743_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/ph14040301","volume":"14","author":"Y Kawano","year":"2021","unstructured":"Kawano, Y. et al. Wound healing promotion by hyaluronic acid: effect of molecular weight on gene expression and In vivo wound closure. Pharmaceuticals (Basel). 14 (4), 301. https:\/\/doi.org\/10.3390\/ph14040301 (2021).","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"91743_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/bjo.2003.027573","volume":"88","author":"JA Gomes","year":"2004","unstructured":"Gomes, J. A., Amankwah, R., Powell-Richards, A. & Dua, H. S. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br. J. Ophthalmol. 88 (6), 821\u2013825. https:\/\/doi.org\/10.1136\/bjo.2003.027573 (2004).","journal-title":"Br. J. Ophthalmol."},{"issue":"12","key":"91743_CR25","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3390\/molecules22122104","volume":"22","author":"A Fallacara","year":"2017","unstructured":"Fallacara, A. et al. Novel artificial tears containing Cross-Linked hyaluronic acid: an In vitro Re-Epithelialization study. Molecules 22 (12), 2104. https:\/\/doi.org\/10.3390\/molecules22122104 (2017).","journal-title":"Molecules"},{"issue":"6","key":"91743_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0014-4835(91)90110-z","volume":"53","author":"T Nishida","year":"1991","unstructured":"Nishida, T., Nakamura, M., Mishima, H. & Otori, T. Hyaluronan stimulates corneal epithelial migration. Exp. Eye Res. 53 (6), 753\u2013758. https:\/\/doi.org\/10.1016\/0014-4835(91)90110-z (1991).","journal-title":"Exp. Eye Res."},{"key":"91743_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jconrel.2020.07.031","volume":"10;326","author":"BC Ilochonwu","year":"2020","unstructured":"Ilochonwu, B. C., Urtti, A., Hennink, W. E. & Vermonden, T. Intravitreal hydrogels for sustained release of therapeutic proteins. J. Control Release. 10;326, 419\u2013441. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.031 (2020).","journal-title":"J. Control Release"},{"key":"91743_CR28","doi-asserted-by":"publisher","first-page":"119577","DOI":"10.1016\/j.ijpharm.2020.119577","volume":"586","author":"PM Campos","year":"2020","unstructured":"Campos, P. M., Petrilli, R. & Lopez, R. F. V. The prominence of the dosage form design to treat ocular diseases. Int. J. Pharm. 586, 119577. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119577 (2020).","journal-title":"Int. J. Pharm."},{"issue":"2","key":"91743_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","volume":"36","author":"MH Goldstein","year":"2022","unstructured":"Goldstein, M. H., Silva, F. Q., Blender, N., Tran, T. & Vantipalli, S. Ocular Benzalkonium chloride exposure: problems and solutions. Eye (Lond). 36 (2), 361\u2013368. https:\/\/doi.org\/10.1038\/s41433-021-01668-x (2022).","journal-title":"Eye (Lond)"},{"issue":"4","key":"91743_CR30","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1167\/iovs.16-20903","volume":"58","author":"S Datta","year":"2017","unstructured":"Datta, S., Baudouin, C., Brignole Baudouin, F., Denoyer, A. & Cortopassi, G. A. The eye drop preservative Benzalkonium chloride potently induces mitochondrial dysfunction and preferentially affects LHON mutant cells. Invest. Ophthalmol. Vis. Sci. 58 (4), 2406\u20132412. https:\/\/doi.org\/10.1167\/iovs.16-20903 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"91743_CR31","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.2147\/OPTH.S41358","volume":"7","author":"LM Rosin","year":"2013","unstructured":"Rosin, L. M. & Bell, N. P. Preservative toxicity in glaucoma medication: clinical evaluation of Benzalkonium chloride-free 0.5% timolol eye drops. Clin. Ophthalmol. 7, 2131\u20132135. https:\/\/doi.org\/10.2147\/OPTH.S41358 (2013).","journal-title":"Clin. Ophthalmol."},{"key":"91743_CR32","doi-asserted-by":"publisher","first-page":"251584142211123","DOI":"10.1177\/25158414221112356","volume":"14","author":"K Kagkelaris","year":"2022","unstructured":"Kagkelaris, K., Panayiotakopoulos, G. & Georgakopoulos, C. D. Nanotechnology-based formulations to amplify intraocular bioavailability. Ther. Adv. Ophthalmol. 14, 25158414221112356. https:\/\/doi.org\/10.1177\/25158414221112356 (2022).","journal-title":"Ther. Adv. Ophthalmol."},{"key":"91743_CR33","doi-asserted-by":"crossref","unstructured":"Campolo, A., Crary, M. & Shannon, P. A. Review of the Containers Available for Multi-Dose Preservative-Free Eye Drops. Biomed J Sci Tech Res. 45(1)-2022. BJSTR. MS.ID.007130 (2022).","DOI":"10.26717\/BJSTR.2022.45.007130"},{"key":"91743_CR34","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0940","author":"PJ Gomes","year":"2023","unstructured":"Gomes, P. J. et al. Bilastine 0.6% preservative-free eye drops, an effective once-daily treatment to reduce signs and symptoms of allergic conjunctivitis: A pooled analysis of two randomized clinical trials. J. Investig Allergol. Clin. Immunol. https:\/\/doi.org\/10.18176\/jiaci.0940 (2023). Published online September 21, 2023.","journal-title":"J. Investig Allergol. Clin. Immunol."},{"issue":"3","key":"91743_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/03007995.2019.1681134","volume":"36","author":"MK Church","year":"2020","unstructured":"Church, M. K., Tiongco-Recto, M., Ridolo, E. & Nov\u00e1k, Z. Bilastine: a lifetime companion for the treatment of allergies. Curr. Med. Res. Opin. 36 (3), 445\u2013454. https:\/\/doi.org\/10.1080\/03007995.2019.1681134 (2020).","journal-title":"Curr. Med. Res. Opin."},{"issue":"9","key":"91743_CR36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2165\/11209310-000000000-00000","volume":"72","author":"NJ Carter","year":"2012","unstructured":"Carter, N. J. Bilastine: in allergic rhinitis and urticaria. Drugs 72 (9), 1257\u20131269. https:\/\/doi.org\/10.2165\/11209310-000000000-00000 (2012).","journal-title":"Drugs"},{"issue":"1","key":"91743_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12948-015-0008-x","volume":"13","author":"E Ridolo","year":"2015","unstructured":"Ridolo, E. et al. Bilastine: new insight into antihistamine treatment. Clin. Mol. Allergy. 13 (1), 1. https:\/\/doi.org\/10.1186\/s12948-015-0008-x (2015).","journal-title":"Clin. Mol. Allergy"},{"issue":"7","key":"91743_CR38","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1007\/s12325-021-01801-y","volume":"38","author":"D Ochoa","year":"2021","unstructured":"Ochoa, D. et al. Pharmacokinetics and safety of a Bilastine Once-Daily, Preservative-Free, ophthalmic formulation. Adv. Ther. 38 (7), 4070\u20134081. https:\/\/doi.org\/10.1007\/s12325-021-01801-y (2021).","journal-title":"Adv. Ther."},{"key":"91743_CR39","doi-asserted-by":"publisher","first-page":"0","DOI":"10.18176\/jiaci.0800","volume":"1","author":"PJ Gomes","year":"2022","unstructured":"Gomes, P. J., Ciolino, J. B., Arranz, P., Hern\u00e1ndez, G. & Fern\u00e1ndez, N. Efficacy of once-daily ophthalmic Bilastine for the treatment of allergic conjunctivitis: a dose-finding study. J. Investig Allergol. Clin. Immunol. 1, 0. https:\/\/doi.org\/10.18176\/jiaci.0800 (2022).","journal-title":"J. Investig Allergol. Clin. Immunol."},{"issue":"8","key":"91743_CR40","first-page":"209","volume":"64","author":"T Suarez-Cortes","year":"2023","unstructured":"Suarez-Cortes, T. et al. The new once-daily multidose preservative-free 0.6% Bilastine eye drop formulation containing sodium hyaluronate preserves ocular surface integrity and tear film homeostasis in a comparative in vivo study. Invest. Ophthalmol. Vis. Sci. 64 (8), 209 (2023).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"91743_CR41","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1139\/z95-253","volume":"73","author":"MJ Doughty","year":"1995","unstructured":"Doughty, M. J., Petrou, S. & Macmillan, H. Anatomy and morphology of the cornea of bovine eyes from a slaughterhouse. Can. J. Zool. 73 (11), 2159\u20132165. https:\/\/doi.org\/10.1139\/z95-253 (1995).","journal-title":"Can. J. Zool."},{"key":"91743_CR42","doi-asserted-by":"publisher","unstructured":"OECD. Test No. 437: Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants (OECD Publishing, 2009). https:\/\/doi.org\/10.1787\/9789264076303-en","DOI":"10.1787\/9789264076303-en"},{"key":"91743_CR43","doi-asserted-by":"publisher","first-page":"120318","DOI":"10.1016\/j.ijpharm.2021.120318","volume":"597","author":"V D\u00edaz-Tom\u00e9","year":"2021","unstructured":"D\u00edaz-Tom\u00e9, V. et al. In situ forming and mucoadhesive ophthalmic Voriconazole\/HP\u03b2CD hydrogels for the treatment of fungal keratitis. Int. J. Pharm. 597, 120318. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120318 (2021).","journal-title":"Int. J. Pharm."},{"issue":"8","key":"91743_CR44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/jop.2014.0164","volume":"31","author":"R Rangarajan","year":"2015","unstructured":"Rangarajan, R., Kraybill, B., Ogundele, A. & Ketelson, H. A. Effects of a hyaluronic acid\/hydroxypropyl Guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium. J. Ocul Pharmacol. Ther. 31 (8), 491\u2013497. https:\/\/doi.org\/10.1089\/jop.2014.0164 (2015).","journal-title":"J. Ocul Pharmacol. Ther."},{"key":"91743_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/7651_2019_259","volume":"2109","author":"S Martinotti","year":"2020","unstructured":"Martinotti, S. & Ranzato, E. Scratch wound healing assay. Methods Mol. Biol. 2109, 225\u2013229 (2020). 10.1007\/7651_2019_259.","journal-title":"Methods Mol. Biol."},{"key":"91743_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1385\/1-59259-860-9:023","volume":"294","author":"LG Rodriguez","year":"2005","unstructured":"Rodriguez, L. G., Wu, X. & Guan, J. L. Wound-healing assay. Methods Mol. Biol. 294, 23\u201329. https:\/\/doi.org\/10.1385\/1-59259-860-9:023 (2005).","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"91743_CR47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 9 (7), 676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019 (2012). Published 2012 Jun 28.","journal-title":"Nat. Methods"},{"issue":"7","key":"91743_CR48","doi-asserted-by":"publisher","first-page":"e0232565","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo, A. et al. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS One. 15 (7), e0232565. https:\/\/doi.org\/10.1371\/journal.pone.0232565 (2020). Published 2020 Jul 28.","journal-title":"PLoS One"},{"issue":"3","key":"91743_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2165\/00137696-200604030-00002","volume":"4","author":"C Alvarez-Lorenzo","year":"2006","unstructured":"Alvarez-Lorenzo, C., Hiratani, H. & Concheiro, A. Contact lenses for drug delivery achieving sustained release with novel systems. Am. J. Drug Deliv. 4 (3), 131\u2013151 (2006).","journal-title":"Am. J. Drug Deliv"},{"key":"91743_CR50","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2147\/OPTH.S157853","volume":"12","author":"AJ Mateo Orobia","year":"2018","unstructured":"Mateo Orobia, A. J., Saa, J., Ollero Lorenzo, A. & Herreras, J. M. Combination of hyaluronic acid, Carmellose, and osmoprotectants for the treatment of dry eye disease. Clin. Ophthalmol. 12, 453\u2013461. https:\/\/doi.org\/10.2147\/OPTH.S157853 (2018).","journal-title":"Clin. Ophthalmol."},{"issue":"11","key":"91743_CR51","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/bjo.79.11.1007","volume":"79","author":"S Shimmura","year":"1995","unstructured":"Shimmura, S. et al. Sodium hyaluronate Eyedrops in the treatment of dry eyes. Br. J. Ophthalmol. 79 (11), 1007\u20131011. https:\/\/doi.org\/10.1136\/bjo.79.11.1007 (1995).","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"91743_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00417-005-0028-1","volume":"244","author":"ME Johnson","year":"2006","unstructured":"Johnson, M. E., Murphy, P. J. & Boulton, M. Effectiveness of sodium hyaluronate Eyedrops in the treatment of dry eye. Graefes Arch. Clin. Exp. Ophthalmol. 244 (1), 109\u2013112. https:\/\/doi.org\/10.1007\/s00417-005-0028-1 (2006).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"3","key":"91743_CR53","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1021\/bm049346i","volume":"6","author":"M Morra","year":"2005","unstructured":"Morra, M. Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules 6 (3), 1205\u20131223. https:\/\/doi.org\/10.1021\/bm049346i (2005).","journal-title":"Biomacromolecules"},{"key":"91743_CR54","doi-asserted-by":"publisher","first-page":"787644","DOI":"10.3389\/fmed.2021.787644","volume":"8","author":"MM Allyn","year":"2022","unstructured":"Allyn, M. M., Luo, R. H., Hellwarth, E. B. & Swindle-Reilly, K. E. Considerations for polymers used in ocular drug delivery. Front. Med. (Lausanne). 8, 787644. https:\/\/doi.org\/10.3389\/fmed.2021.787644 (2022).","journal-title":"Front. Med. (Lausanne)"},{"issue":"2","key":"91743_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1517\/14656566.2010.518612","volume":"12","author":"M Dogru","year":"2011","unstructured":"Dogru, M. & Tsubota, K. Pharmacotherapy of Dryeye. Expert Opin. Pharmacother. 12 (2), 325\u2013334 (2011).","journal-title":"Expert Opin. Pharmacother"},{"key":"91743_CR56","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/OPX.0b013e3181824de3","volume":"85","author":"JR Paugh","year":"2008","unstructured":"Paugh, J. R., Nguyen, A. L., Ketelson, H. A., Christen-sen, M. T. & Meadows, D. L. Precorneal residence timeof artificial tears measured in dry eye subjects. Optom. Vis. Sci. 85, 725\u2013731 (2008).","journal-title":"Optom. Vis. Sci."},{"key":"91743_CR57","doi-asserted-by":"publisher","unstructured":"Hornby, S., Rizer, R. L. & Appa, Y. Therapeutic glycerin-based ointment provides healing benefits. J. Am. Acad. Dermatol. 60 (3). https:\/\/doi.org\/10.1016\/j.jaad.2008.11.880 (2009). suppl. 1, AB203.","DOI":"10.1016\/j.jaad.2008.11.880"},{"key":"91743_CR58","doi-asserted-by":"publisher","unstructured":"Sezgin, S. et al. An experimental study on the comparison of the effects of triester glycerol oxide on wound repair. Oral Maxillofac Surg. 20(3):273-9; (2017). https:\/\/doi.org\/10.1007\/s10006-016-0566-1. Erratum in: Oral Maxillofac Surg. ;21(1):107 (2016).","DOI":"10.1007\/s10006-016-0566-1"},{"key":"91743_CR59","doi-asserted-by":"publisher","first-page":"105736","DOI":"10.1016\/j.ejps.2021.105736","volume":"159","author":"LL Tundisi","year":"2021","unstructured":"Tundisi, L. L., Mosta\u00e7o, G. B., Carricondo, P. C. & Petri, D. F. S. Hydroxypropyl Methylcellulose: physicochemical properties and ocular drug delivery formulations. Eur. J. Pharm. Sci. 159, 105736. https:\/\/doi.org\/10.1016\/j.ejps.2021.105736 (2021).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"91743_CR60","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/jop.2018.0151","volume":"35","author":"C Posarelli","year":"2019","unstructured":"Posarelli, C. et al. Cross-Linked hyaluronic acid as tear film substitute. J. Ocul Pharmacol. Ther. 35 (7), 381\u2013387. https:\/\/doi.org\/10.1089\/jop.2018.0151 (2019).","journal-title":"J. Ocul Pharmacol. Ther."},{"issue":"2","key":"91743_CR61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/pharmaceutics13020207","volume":"13","author":"P Agarwal","year":"2021","unstructured":"Agarwal, P., Craig, J. P. & Rupenthal, I. D. Formulation considerations for the management of dry eye disease. Pharmaceutics 13 (2), 207. https:\/\/doi.org\/10.3390\/pharmaceutics13020207 (2021).","journal-title":"Pharmaceutics"},{"key":"91743_CR62","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/all.15097","volume":"76","author":"E Arana","year":"2021","unstructured":"Arana, E. et al. New preservative-free once-daily 0.6% Bilastine multidose eye drops containing sodium hyaluronate preserve the ocular surface epithelial integrity in a comparative in vitro study. Abstracts Allergy. 76, 583\u2013637. https:\/\/doi.org\/10.1111\/all.15097 (2021).","journal-title":"Abstracts Allergy"},{"key":"91743_CR63","doi-asserted-by":"publisher","unstructured":"Zhong, J. et al. Hyaluronate Acid-Dependent Protection and Enhanced Corneal Wound Healing against Oxidative Damage in Corneal Epithelial Cells. J Ophthalmol. :6538051; (2016). https:\/\/doi.org\/10.1155\/2016\/6538051 (2016).","DOI":"10.1155\/2016\/6538051"},{"issue":"7","key":"91743_CR64","first-page":"2313","volume":"34","author":"M Inoue","year":"1993","unstructured":"Inoue, M. & Katakami, C. The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest. Ophthalmol. Vis. Sci. 34 (7), 2313\u20132315 (1993).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"91743_CR65","first-page":"355","volume":"10","author":"PH Weigel","year":"1988","unstructured":"Weigel, P. H., Frost, S. J., McGary, C. T. & LeBoeuf, R. D. The role of hyaluronic acid in inflammation and wound healing. Int. J. Tissue React. 10 (6), 355\u2013365 (1988).","journal-title":"Int. J. Tissue React."},{"key":"91743_CR66","first-page":"577","volume":"15","author":"T Pauloin","year":"2009","unstructured":"Pauloin, T., Dutot, M., Joly, F., Warnet, J. M. & Rat, P. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol. Vis. 15, 577\u2013583 (2009).","journal-title":"Mol. Vis."},{"key":"91743_CR67","first-page":"3364","volume":"17","author":"H Wu","year":"2011","unstructured":"Wu, H. et al. Genoprotective effect of hyaluronic acid against Benzalkonium chloride-induced DNA damage in human corneal epithelial cells. Mol. Vis. 17, 3364\u20133370 (2011).","journal-title":"Mol. Vis."},{"issue":"1","key":"91743_CR68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/jop.1999.15.59","volume":"15","author":"CP Lin","year":"1999","unstructured":"Lin, C. P. & Boehnke, M. Influences of Methylcellulose on corneal epithelial wound healing. J. Ocul Pharmacol. Ther. 15 (1), 59\u201363. https:\/\/doi.org\/10.1089\/jop.1999.15.59 (1999).","journal-title":"J. Ocul Pharmacol. Ther."},{"issue":"4","key":"91743_CR69","first-page":"136","volume":"5","author":"K Shahraki","year":"2016","unstructured":"Shahraki, K. et al. Effects of topical 1% sodium hyaluronate and hydroxypropyl Methylcellulose in treatment of corneal epithelial defects. Med. Hypothesis Discov Innov. Ophthalmol. 5 (4), 136\u2013144 (2016).","journal-title":"Med. Hypothesis Discov Innov. Ophthalmol."},{"issue":"11","key":"91743_CR70","doi-asserted-by":"publisher","first-page":"e0208198","DOI":"10.1371\/journal.pone.0208198","volume":"13","author":"M Fukuda","year":"2018","unstructured":"Fukuda, M. et al. Polyvinyl alcohol-iodine induced corneal epithelial injury in vivo and its protection by topical rebamipide treatment. PLoS One. 13 (11), e0208198. https:\/\/doi.org\/10.1371\/journal.pone.0208198 (2018).","journal-title":"PLoS One"},{"issue":"1","key":"91743_CR71","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/15569527.2019.1673402","volume":"39","author":"S Seino","year":"2020","unstructured":"Seino, S. et al. Topical hyaluronan alone promotes corneal epithelial cell migration whereas combination with Benzalkonium chloride impairs epithelial wound healing. Cutan. Ocul Toxicol. 39 (1), 13\u201320. https:\/\/doi.org\/10.1080\/15569527.2019.1673402 (2020).","journal-title":"Cutan. Ocul Toxicol."},{"issue":"9","key":"91743_CR72","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00417-012-1999-3","volume":"250","author":"N Schrage","year":"2012","unstructured":"Schrage, N., Frentz, M. & Spoeler, F. The ex vivo eye irritation test (EVEIT) in evaluation of artificial tears: Purite-preserved versus unpreserved eye drops. Graefes Arch. Clin. Exp. Ophthalmol. 250 (9), 1333\u20131340. https:\/\/doi.org\/10.1007\/s00417-012-1999-3 (2012).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"91743_CR73","doi-asserted-by":"publisher","unstructured":"Liang, H., Baudouin, C., Daull, P., Garrigue, J. S. & Brignole-Baudouin, F. In Vitro Corneal and Conjunctival Wound-Healing Assays as a Tool for Antiglaucoma Prostaglandin Formulation Characterization. Front Biosci (Landmark Ed). 27(5):147. (2022). https:\/\/doi.org\/10.31083\/j.fbl2705147. PMID: 35638414.","DOI":"10.31083\/j.fbl2705147"},{"issue":"10","key":"91743_CR74","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.3390\/ijms21103516","volume":"21","author":"T Kojima","year":"2020","unstructured":"Kojima, T. et al. The effects of high molecular weight hyaluronic acid eye drop application in environmental dry eye stress model mice. Int. J. Mol. Sci. 21 (10), 3516. https:\/\/doi.org\/10.3390\/ijms21103516 (2020). PMID: 32429217; PMCID: PMC727891.","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91743-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91743-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91743-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:56:36Z","timestamp":1741337796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91743-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91743"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91743-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"6 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: EA, GH, AG and TSC are employees of FAES FARMA SA (Spain). FO, VD, FG, and PGF received fees from FAES FARMA SA (Spain) through subcontracting analyses during the conduct of the study. NA and MPG declare no potential conflict of interest. EA was granted a partial scholarship by Basque Government \u2013 BIKAINTEK Program (48-AF-W2-2018-00008). This work was partially supported by the Basque Country Government (Economic Development & Infrastructures Depart.), HAZITEK program [grant No. ZE-2019\/00004]. The funding organizations had no role in the study design, data collection, decision to publish, or preparation of manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7987"}}